MapLight (MPLT) CSO Lillie James Woodruff Sells 22,082 Shares

What Happened

• Lillie James Woodruff, Chief Scientific Officer of MapLight Therapeutics, sold 22,082 shares on August 3, 2026. The filing reports a weighted-average sale price of $12.54 per share for a total proceeds of approximately $276,908. The transaction is coded as a sale (S) and was executed under a previously adopted Rule 10b5-1 trading plan.

Key Details

• Transaction date: 2026-08-03; Form 4 filed: 2026-08-04 (timely).
• Price: weighted average $12.54; actual sale prices ranged from $12.12 to $12.99 across multiple trades (report notes availability of per-price breakdown on request).
• Shares sold: 22,082; total reported proceeds ≈ $276,908.
• Shares owned after transaction: not specified in the provided filing details.
• Notable footnotes: (F1) sale made pursuant to a 10b5-1 plan adopted Dec 29, 2025; (F2) reported price is a weighted average with range $12.12–$12.99 and the reporting person will supply per-trade breakdown if requested.
• Filing timeliness: not late (filed one day after the transaction date).

Context

• This was a sale under a pre-established 10b5-1 plan, which schedules trades in advance and can reflect routine portfolio management rather than a contemporaneous view of the company. Sales (S) are generally less strong a signal for bullish conviction than purchases. No options were exercised, no awards or gifts were reported in this filing.